Telix Expands Prostate Cancer Activity with GenesisCare Collaboration

Go back to Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.44 --0 (-0%)
Previous Close $9.44    52 Week High $2.18 
Open $9.44    52 Week Low $0.30 
Day High $9.44    P/E N/A 
Day Low $9.44    EPS $-3.32 
Volume 11